These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C. EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193 [Abstract] [Full Text] [Related]
3. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. Teran M, Nugent MA. J Biol Chem; 2015 Jun 26; 290(26):16451-62. PubMed ID: 25979342 [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L. Cancer Res; 2008 Jun 15; 68(12):4683-92. PubMed ID: 18559514 [Abstract] [Full Text] [Related]
5. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor. Ueda N, Inder MK, Wise LM, Fleming SB, Mercer AA. Virus Res; 2007 Mar 15; 124(1-2):50-8. PubMed ID: 17109982 [Abstract] [Full Text] [Related]
6. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Zheng Y, Murakami M, Takahashi H, Yamauchi M, Kiba A, Yamaguchi S, Yabana N, Alitalo K, Shibuya M. Arterioscler Thromb Vasc Biol; 2006 Sep 15; 26(9):2019-26. PubMed ID: 16794222 [Abstract] [Full Text] [Related]
7. Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. Ballmer-Hofer K, Andersson AE, Ratcliffe LE, Berger P. Blood; 2011 Jul 21; 118(3):816-26. PubMed ID: 21586748 [Abstract] [Full Text] [Related]
8. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cébe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellén L, Klagsbrun M, Claesson-Welsh L. Blood; 2008 Nov 01; 112(9):3638-49. PubMed ID: 18664627 [Abstract] [Full Text] [Related]
9. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells. Ohsaka A, Hirota-Komatsu S, Shibata M, Komatsu N. Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1171-6. PubMed ID: 19857463 [Abstract] [Full Text] [Related]
10. The C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1. Inder MK, Wise LM, Fleming SB, Mercer AA. FEBS J; 2008 Jan 25; 275(1):207-17. PubMed ID: 18076652 [Abstract] [Full Text] [Related]
11. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. Uniewicz KA, Cross MJ, Fernig DG. J Biol Chem; 2011 Jan 07; 286(1):12-23. PubMed ID: 20956519 [Abstract] [Full Text] [Related]
12. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY. Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272 [Abstract] [Full Text] [Related]
13. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. FASEB J; 2007 Mar 17; 21(3):915-26. PubMed ID: 17185751 [Abstract] [Full Text] [Related]
14. Neuropilin signalling in angiogenesis. Koch S. Biochem Soc Trans; 2012 Feb 17; 40(1):20-5. PubMed ID: 22260660 [Abstract] [Full Text] [Related]
15. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE. Cancer Res; 2005 May 01; 65(9):3664-70. PubMed ID: 15867361 [Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Wise LM, Veikkola T, Mercer AA, Savory LJ, Fleming SB, Caesar C, Vitali A, Makinen T, Alitalo K, Stacker SA. Proc Natl Acad Sci U S A; 1999 Mar 16; 96(6):3071-6. PubMed ID: 10077638 [Abstract] [Full Text] [Related]
17. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells. Heil M, Mitnacht-Krauss R, Issbrücker K, van den Heuvel J, Dehio C, Schaper W, Clauss M, Weich HA. Angiogenesis; 2003 Mar 16; 6(3):201-11. PubMed ID: 15041796 [Abstract] [Full Text] [Related]
18. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Starzec A, Ladam P, Vassy R, Badache S, Bouchemal N, Navaza A, du Penhoat CH, Perret GY. Peptides; 2007 Dec 16; 28(12):2397-402. PubMed ID: 17983687 [Abstract] [Full Text] [Related]
19. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF. Liu W, Parikh AA, Stoeltzing O, Fan F, McCarty MF, Wey J, Hicklin DJ, Ellis LM. Cytokine; 2005 Dec 07; 32(5):206-12. PubMed ID: 16289960 [Abstract] [Full Text] [Related]
20. Unique signal transduction of the VEGF family members VEGF-A and VEGF-E. Shibuya M. Biochem Soc Trans; 2009 Dec 07; 37(Pt 6):1161-6. PubMed ID: 19909239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]